The elevated expression of CAIX, however, has been independently associated with poor prognosis in a growing number of tumor types, including those of breast, lung, cervix, head and neck, rectal and brain [3], [5], [6], [10], [17], making it an attractive target for diagnostic non-invasive imaging and also as a potential biomarker of treatment response. Here, CA9 is linked to neoplasm.